Emil D. Kakkis

Insider Reports History

Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Emil D. Kakkis:

Insider Reports Filed by Emil D. Kakkis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RARE Ultragenyx Pharmaceutical Inc. Feb 28, 2025 5 -$4.15M 4 Mar 4, 2025 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Dec 30, 2024 1 -$495K 4 Dec 31, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Dec 9, 2024 2 -$414K 4 Dec 11, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Sep 3, 2024 1 -$1.12M 4 Sep 5, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Aug 6, 2024 1 -$1M 4 Aug 7, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2024 4 -$935K 4 Mar 5, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Feb 7, 2024 1 -$1.35M 4 Feb 8, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Dec 29, 2023 1 -$1.44M 4 Jan 2, 2024 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Oct 19, 2023 3 -$1.28M 4 Oct 23, 2023 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2023 4 -$737K 4 Mar 3, 2023 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Dec 30, 2022 1 -$892K 4 Jan 3, 2023 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2022 3 -$819K 4 Mar 3, 2022 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Dec 31, 2021 1 $0 5 Feb 1, 2022 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. Oct 14, 2021 1 -$69.1K 4 Oct 18, 2021 President & CEO, Director
RARE Ultragenyx Pharmaceutical Inc. May 6, 2021 1 -$98.6K 4 May 10, 2021 President & CEO, Director